Screener
USANA Health Sciences USNA Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 77.4%-2.5pp | 77.6%-3.0pp | 78.3%-2.8pp | 79.2%-1.7pp | 79.9%-0.8pp | |
| Operating margin | -0.1%-6.4pp | 3.8%-2.7pp | 4%-3.7pp | 4.6%-5.0pp | 6.2%-3.4pp | |
| Efficiency | ||||||
| Asset turnover | 1.3×0.0× | 1.2×0.0× | 1.2×0.0× | 1.3×0.0× | 1.3×-0.1× | |
| Liquidity | ||||||
| Current ratio | 2.7×+0.5× | 2.5×+0.5× | 2.2×+0.2× | 2.2×-1.7× | 2.2×-1.9× | |
| Per Share | ||||||
| Book value per share | $28.47-0.6% | $29.52+6.4% | $28.70+3.4% | $28.87+3.3% | $28.65+7.2% | |
| Valuation | ||||||
| Market capitalization | $267.36M-47.0% | $351.6M-31.2% | $396.69M-36.1% | $386.45M-45.2% | $547.33M-35.7% | |
| Price / sales | 0.3×-0.3× | 0.4×-0.2× | 0.4×-0.3× | 0.4×-0.4× | 0.6×-0.4× | |
| Price / book | 0.5×-0.4× | 0.6×-0.3× | 0.7×-0.4× | 0.7×-0.6× | 1×-0.6× |
FAQ
- What are USANA Health Sciences's profit margins?
- USANA Health Sciences (USNA) runs a 77.4% gross margin and a -0.1% operating margin, with a 1.9% net margin.
- Where do USANA Health Sciences's ratios come from?
- Every ratio is computed from USANA Health Sciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
